Trabectedin use in soft‐tissue sarcoma patients in a real‐world setting: Data from an Italian national drug‐access registry-Reference-Cited by-同舟云学术

Trabectedin use in soft‐tissue sarcoma patients in a real‐world setting: Data from an Italian national drug‐access registry

Published:2022-10-13 Issue:4 Volume:152 Page:761-768
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Vincenzi Bruno¹^ORCID,Napolitano Andrea¹²^ORCID,Comandone Alessandro³,Sanfilippo Roberta⁴^ORCID,Celant Simone⁵,Olimpieri Pier P.⁵,Di Segni Susanna⁵,Russo Pierluigi⁵^ORCID,Casali Paolo G.⁴⁶^ORCID

Affiliation:

1. University Campus Bio‐Medico Rome Italy

2. Royal Marsden NHS Foundation Trust London UK

3. Humanitas Gradenigo Hospital Turin Italy

4. Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

5. Italian Medicines Agency Rome Italy

6. University of Milan Milan Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34309

Reference19 articles.

1. Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectives

2. Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients

3. Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy

4. Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial

5. Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models;Oncogene;2024-08-28

2. Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study;The Lancet Regional Health - Europe;2024-06

3. Centralisation of care improves overall survival for sarcoma patients;Annals of Oncology;2024-04

4. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment—Progresses in Their Use in Combined Cancer Therapy;Molecules;2024-01-09

5. Chemotherapeutic drugs for soft tissue sarcomas: a review;Frontiers in Pharmacology;2023-08-11